AU461338B2 - Method and pharmaceutical compositions for inhibiting gluconeogenesis - Google Patents

Method and pharmaceutical compositions for inhibiting gluconeogenesis

Info

Publication number
AU461338B2
AU461338B2 AU40754/72A AU4075472A AU461338B2 AU 461338 B2 AU461338 B2 AU 461338B2 AU 40754/72 A AU40754/72 A AU 40754/72A AU 4075472 A AU4075472 A AU 4075472A AU 461338 B2 AU461338 B2 AU 461338B2
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
inhibiting gluconeogenesis
gluconeogenesis
inhibiting
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU40754/72A
Other versions
AU4075472A (en
Inventor
NICHOLAS WILLIAM DITULLIO and JERRY ARNOLD WEINBACH CHARLES EDWARD BERKOFF
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of AU4075472A publication Critical patent/AU4075472A/en
Application granted granted Critical
Publication of AU461338B2 publication Critical patent/AU461338B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU40754/72A 1971-04-06 1972-04-04 Method and pharmaceutical compositions for inhibiting gluconeogenesis Expired AU461338B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13183471A 1971-04-06 1971-04-06
USUS131,834 1971-04-06

Publications (2)

Publication Number Publication Date
AU4075472A AU4075472A (en) 1973-10-11
AU461338B2 true AU461338B2 (en) 1975-05-06

Family

ID=22451218

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40754/72A Expired AU461338B2 (en) 1971-04-06 1972-04-04 Method and pharmaceutical compositions for inhibiting gluconeogenesis

Country Status (8)

Country Link
AU (1) AU461338B2 (en)
BE (1) BE781416A (en)
DE (1) DE2216576A1 (en)
FR (1) FR2132398B1 (en)
GB (1) GB1316069A (en)
IL (1) IL39088A (en)
NL (1) NL7204458A (en)
ZA (1) ZA722084B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2245935A1 (en) 2009-05-02 2010-11-03 Bayer CropScience AG Herbicide compounds based on N-Azinyl-N-pyridylsulfonyl-uric substances

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639413A (en) * 1969-09-26 1972-02-01 Dow Chemical Co (thio- sulfinyl- and sulfonyl) containing pyridine compounds

Also Published As

Publication number Publication date
FR2132398A1 (en) 1972-11-17
IL39088A0 (en) 1972-05-30
GB1316069A (en) 1973-05-09
AU4075472A (en) 1973-10-11
DE2216576A1 (en) 1972-10-19
FR2132398B1 (en) 1975-12-26
BE781416A (en) 1972-09-29
NL7204458A (en) 1972-10-10
IL39088A (en) 1975-08-31
ZA722084B (en) 1972-12-27

Similar Documents

Publication Publication Date Title
AU482733B2 (en) Pharmaceutical compositions
CA972653A (en) Compositions and methods for controlling scale
CA978044A (en) Methods and compositions for inhibiting scale formation
AU468490B2 (en) Furylmethyl morphinane derivatives and pharmaceutical compositions containing them
CA974170A (en) Pharmaceutical compositions
AU461338B2 (en) Method and pharmaceutical compositions for inhibiting gluconeogenesis
AU461136B2 (en) Pharmaceutical composition
CA880873A (en) Pharmaceutical composition and method
CA868860A (en) Composition and method for inhibiting and removing scale
CA867713A (en) Composition and method for inhibiting and removing scale
CA1000283A (en) Amino-indazole compounds, processes for making them and pharmaceutical compositions containing them
AU467573B2 (en) Pharmaceutical compositions and method
CA884280A (en) Method of making pharmaceutical compositions
AU434299B2 (en) Composition and method for inhibiting sulphide cracking
AU450264B2 (en) Method of and compositions for protecting surfaces
CA876689A (en) Pharmaceutical compositions
CA882088A (en) Pharmaceutical compositions
CA884860A (en) Pharmaceutical compositions
CA888155A (en) Pharmaceutical compositions
CA888688A (en) Pharmaceutical compositions
CA884856A (en) Pharmaceutical compositions
CA881476A (en) Pharmaceutical compositions
CA879074A (en) Pharmaceutical compositions
CA903429A (en) Method and compositions for cable-blocking
CA882573A (en) Process for inhibiting corrosion and compositions for use therein